“Quercetin as a PI3K/Akt Pathway Inhibitor in Hepatocellular Carcinoma: Therapeutic Potential and Drug Delivery Challenges”, CAJMNS, vol. 7, no. 2, pp. 493–501, Apr. 2026, doi: 10.51699/cajmns.v7i2.3191.